Asherman's Syndrome: A Comprehensive Review of Pathophysiology, Diagnosis, and Treatment Strategies
Main Article Content
Abstract
Asherman's Syndrome, also known as intrauterine adhesions or synechiae, is a rare but clinically significant condition characterized by the formation of fibrous tissue within the uterine cavity, resulting in adhesions and obliteration of the endometrial cavity. This condition often leads to a spectrum of menstrual disturbances, infertility, and recurrent pregnancy loss. The purpose of this comprehensive review article is to elucidate the multifaceted aspects of Asherman's Syndrome, encompassing its pathophysiological mechanisms, diagnostic challenges, and various treatment modalities. A thorough understanding of this syndrome is crucial for healthcare providers to offer optimal care and management options to affected patients, ultimately improving their reproductive outcomes and quality of life.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Queckbörner S, Davies LC, von Grothusen C, Santamaria X, Simón C, Gemzell-Danielsson K. Cellular therapies for the endometrium: An update. Acta Obstet Gynecol Scand. 2019 May;98(5):672-677.
Guo EJ, Chung JPW, Poon LCY, Li TC. Reproductive outcomes after surgical treatment of asherman syndrome: A systematic review. Best Pract Res Clin Obstet Gynaecol. 2019 Aug;59:98-114.
Ludwin A, Martins WP, Ludwin I. Ultrasound-guided repeat intrauterine balloon dilatation for prevention of adhesions. Ultrasound Obstet Gynecol. 2019 Oct;54(4):566-568. [PubMed]
Chikazawa K, Imai K, Liangcheng W, Sasaki S, Horiuchi I, Kuwata T, Takagi K. Detection of Asherman's syndrome after conservative management of placenta accreta: a case report. J Med Case Rep. 2018 Nov 20;12(1):344.
Al-Inany H. Intrauterine adhesions. An update. Acta Obstet Gynecol Scand. 2001 Nov;80(11):986-93.
Tchente NC, Brichant G, Nisolle M. [Asherman's syndrome : management after curettage following a postnatal placental retention and literature review]. Rev Med Liege. 2018 Oct;73(10):508-512.
ASIMAKOPULOS N. TRAUMATIC INTRAUTERINE ADHESIONS. (THE FRITSCH-ASHERMAN SYNDROME). Can Med Assoc J. 1965 Aug 14;93(7):298-302.
Young BK. A multidisciplinary approach to pregnancy loss: the pregnancy loss prevention center. J Perinat Med. 2018 Dec 19;47(1):41-44.
Capmas P, Pourcelot AG, Fernandez H. Are synechiae a complication of laparotomic myomectomy? Reprod Biomed Online. 2018 Apr;36(4):450-454.
Dreisler E, Kjer JJ. Asherman's syndrome: current perspectives on diagnosis and management. Int J Womens Health. 2019;11:191-198.
Azizi R, Aghebati-Maleki L, Nouri M, Marofi F, Negargar S, Yousefi M. Stem cell therapy in Asherman syndrome and thin endometrium: Stem cell- based therapy. Biomed Pharmacother. 2018 Jun;102:333-343.
Zheng F, Zhu B, Liu Y, Wang R, Cui Y. Meta-analysis of the use of amniotic membrane to prevent recurrence of intrauterine adhesion after hysteroscopic adhesiolysis. Int J Gynaecol Obstet. 2018 Nov;143(2):145-149.
Khan Z, Goldberg JM. Hysteroscopic Management of Asherman's Syndrome. J Minim Invasive Gynecol. 2018 Feb;25(2):218-228.
Deans R, Vancaillie T, Ledger W, Liu J, Abbott JA. Live birth rate and obstetric complications following the hysteroscopic management of intrauterine adhesions including Asherman syndrome. Hum Reprod. 2018 Oct 01;33(10):1847-1853.